Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial

被引：0
|
作者：
Nils Venhoff
Wolfgang A. Schmidt
Peter Lamprecht
Hans-Peter Tony
Christine App
Christian Sieder
Carolin Legeler
Claudia Jentzsch
Jens Thiel
机构：
[1] Klinik für Rheumatologie und Klinische Immunologie,Department Innere Medizin
[2] Vaskulitiszentrum Freiburg,Department of Immunology, Hepatology & Dermatology
[3] Universitätsklinikum Freiburg,undefined
[4] Immanuel Krankenhaus Berlin,undefined
[5] Klinik für Innere Medizin,undefined
[6] Abteilung Rheumatologie und Klinische Immunologie in Berlin-Buch,undefined
[7] Universität zu Lübeck,undefined
[8] Klinik für Rheumatologie und klinische Immunologie,undefined
[9] Medizinische Klinik II,undefined
[10] Universitätsklinik,undefined
[11] Rheumatology/Immunology,undefined
[12] Novartis Pharma GmbH,undefined
[13] Novartis Pharma AG,undefined
来源：
Trials | / 22卷
关键词：
Giant cell arteritis; Secukinumab; Phase II trial; Placebo; Double-blind;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
    Lee, Su Won
    Choi, Jin Kwan
    Lyu, Yee Ran
    Yang, Won Kyung
    Kim, Seung Hyung
    Kim, Je Hyun
    Kim, Si Yeon
    Kang, Weechang
    Jung, In Chul
    Lee, Beom Joon
    Choi, Jun Yong
    Kim, Taesoo
    Park, Yang Chun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [32] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
    Lee, Su Won
    Choi, Jin Kwan
    Lyu, Yee Ran
    Yang, Won Kyung
    Kim, Seung Hyung
    Kim, Je Hyun
    Kim, Si Yeon
    Kang, Weechang
    Jung, In Chul
    Lee, Beom Joon
    Choi, Jun Yong
    Kim, Taesoo
    Park, Yang Chun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [33] Efficacy and Safety of Bojungikgi-Tang for Persistent Allergic Rhinitis: A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
    Lee, Su Won
    Choi, Jin Kwan
    Lyu, Yee Ran
    Yang, Won Kyung
    Kim, Seung Hyung
    Kim, Je Hyun
    Kim, Si Yeon
    Kang, Weechang
    Jung, In Chul
    Lee, Beom Joon
    Choi, Jun Yong
    Kim, Taesoo
    Park, Yang Chun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [34] EFFICACY AND SAFETY OF SUBCUTANEOUS TOCILIZUMAB IN JAPANESE PATIENTS WITH REFRACTORY TAKAYASU ARTERITIS: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Nakaoka, Yoshikazu
    Isobe, Mitsuaki
    Takei, Syuji
    Tanaka, Yoshiya
    Ishii, Tomonori
    Yokota, Shumpei
    Nomura, Akira
    Yoshida, Seitaro
    Nishimoto, Norihiro
    RHEUMATOLOGY, 2017, 56 : 27 - 27
  • [35] Efficacy and Safety of Dichlorphenamide for the Treatment of Periodic Paralysis: a Phase 3 Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
    Burge, James
    Sansone, Valeria
    McDermott, Michael
    Smith, Patty
    Herr, Barbara
    Tawil, Alrabi
    Pandya, Shree
    Kissel, John
    Ciafaloni, Emma
    Shieh, Perry
    Ralph, Jeffrey
    Amato, Anthony
    Cannon, Stephen
    Trivedi, Jaya
    Barohn, Richard
    Crum, Brian
    Mitsumoto, Hiroshi
    Pestronk, Alan
    Meola, Giovanni
    Conwit, Robin
    Jasek, Mark
    Hanna, Michael
    Griggs, Robert
    NEUROLOGY, 2016, 86
  • [36] Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial
    Yuanlong Sun
    Na Hu
    Gaofeng Chen
    Yanjie Wang
    Yiyang Hu
    Maojun Ge
    Yu Zhao
    Trials, 23
  • [37] Efficacy and safety of Qushi Huayu granule for hyperlipidemia: study protocol for a randomized, double-blind, placebo-controlled trial
    Sun, Yuanlong
    Hu, Na
    Chen, Gaofeng
    Wang, Yanjie
    Hu, Yiyang
    Ge, Maojun
    Zhao, Yu
    TRIALS, 2022, 23 (01)
  • [38] Efficacy and Safety of Upadacitinib in Patients with Giant Cell Arteritis (SELECT-GCA): A Double-Blind, Randomized Controlled Phase 3 Trial
    Merkel, Peter
    Penn, Sara
    Setty, Arathi
    Schmidt, Wolfgang
    Rubbert-Roth, Andrea
    Hauge, Ellen Margrethe
    Keen, Helen
    Ishii, Tomonori
    Khalidi, Nader
    Meng, Liu
    Zhao, Weihan
    Lagunes, Ivan
    Romero, Ana B.
    Wung, Peter
    Blockmans, Daniel
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1607 - 1610
  • [39] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENT SUBGROUPS WITH NEW-ONSET AND RELAPSING GIANT CELL ARTERITIS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Stone, John H.
    Tuckwell, Katie
    Dimonaco, Sophie
    Klearman, Micki
    Aringer, Martin
    Blockmans, Daniel
    Brouwer, Elisabeth
    Cid, Maria C.
    Dasgupta, Bhaskar
    Rech, Juergen
    Salavarani, Carlo
    Spiera, Robert
    Unizony, Sebastian
    Collinson, Neil
    RHEUMATOLOGY, 2017, 56 : 11 - 12
  • [40] The efficacy and safety of the herbal medicine geonchildan for patients with active rheumatoid arthritis: study protocol for a randomized, double-blind, placebo-controlled, parallel pilot trial
    Seunghoon Lee
    Yeeun Cho
    Jihye Kim
    Jung Won Kang
    Ga Young Yoon
    Jun-Hwan Lee
    So-Young Jung
    Ojin Kwon
    Kyung-Min Shin
    Jae-Dong Lee
    Trials, 19
12345